In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra individuals are going to be enrolled on the determined monotherapy dosign program. In Phase B, contributors will receive oral ruxolitinib and ABBV-744 is going to be specified as "add-on" therapy. https://cruziwjvm.blogacep.com/37235741/the-fact-about-abbv-744-in-combination-with-immunotherapy-that-no-one-is-suggesting